Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Bifidobacterium animalis is a probiotic bacterium that has been studied for its potential benefits in managing symptoms of Irritable Bowel Syndrome (IBS). There is moderate scientific evidence supporting its use, particularly for the subspecies Bifidobacterium animalis subsp. lactis. Several randomized controlled trials and meta-analyses have investigated the efficacy of B. animalis in alleviating IBS symptoms such as abdominal pain, bloating, and irregular bowel movements. For example, studies using the strain B. animalis subsp. lactis DN-173 010 (often found in certain yogurts) have shown improvements in stool frequency and consistency, especially in IBS patients with constipation-predominant symptoms. A 2014 meta-analysis (Ford et al., 2014) concluded that certain probiotics, including B. animalis, may provide a modest benefit in global IBS symptoms and abdominal pain. However, the quality of evidence varies, with some studies showing significant improvements and others demonstrating minimal or no benefit. The differences often depend on the strain used, the formulation, and study methodology. Probiotic therapy is generally considered safe, and B. animalis is commonly included in commercial probiotic products targeted at digestive health. In summary, while there is scientific validation for the use of Bifidobacterium animalis in IBS, the evidence is moderate rather than robust, warranting a cautious but optimistic approach to its use in this context.

More about Bifidobacterium animalis
More about Irritable Bowel Syndrome

Other ingredients used for Irritable Bowel Syndrome

Other health conditions supported by Bifidobacterium animalis

Products containing Bifidobacterium animalis